Rivpra Formulations enters into D2C market with Oteria

Sharing is caring!

India, April 17, 2024: Rivpra Formulation, an integrated pharmaceutical company, today announced its entry into the D2C segment with the launch of its latest venture – a premium skincare brand, Oteria. Built on the concept of ‘circadian rhythm,’ Oteria is a gender-neutral brand providing holistic skincare solutions for both men and women. With a comprehensive approach to skin, hair, and body care, Oteria has launched 19 products and plans to launch 30 more products by 2026. With these product lines, the company aims to focus on promoting awareness of skin nourishment based on one’s circadian rhythm.

Oteria Skincare

 With more than 20 years in the market, Rivpra Formulation merges pharmaceutical expertise with its very own state-of-the-art facility to research, test, develop, and innovate products within Oteria’s portfolio, in line with the human body’s natural rhythm. Each ingredient undergoes testing in our own well-equipped labs so that we deliver high-quality efficacious products to consumers. Following its debut, all skincare products will be available on e-commerce platforms like Amazon, Flipkart, and Oteria’s direct-to-consumer (D2C) platform. The company is also planning to launch the products on Nykaa, Foxy, Tira beauty, and quick-commerce platforms such as Zepto and Blinkit.

 Commenting on the new launch, Vibhor Rastogi, Director, Rivpra Formulation Pvt. Ltd. shared, “Amidst the backdrop of the COVID-19 pandemic, there has been a notable surge in online shopping that reflects an increasing comfort level among consumers towards e-commerce platforms. This trend underscores a significant shift in consumer behaviour towards digital retail channels. Keeping that in mind, for Oteria, our primary focus is to connect directly with consumers by bringing our products to their doorsteps by partnering with the e- commerce and quick-commerce platforms whilst educating them about the importance of understanding one’s rhythm, for the holistic benefits of their skin. As an organisation, we are committed to developing inclusive, accessible skincare for all. The launch of Oteria cements the start of an exciting journey in the skincare industry and presents an opportunity for us to directly engage with consumers to continue providing solutions, specific to consumer needs.”

 All of Oteria’s product line is manufactured at Rivpra Formulation’s independent manufacturing unit located in Sidcul, Haridwar which spans over 1,00,000 sq. ft through its subsidiary Medisch Lifesciences (distribution channel).

 Rivpra Formulation is a pharmaceutical company with a state-of-the-art infrastructure set up in compliance with WHO-cGMP standards. Rivpra Formulation takes pride in testing and developing products, in line with the human body’s circadian rhythm and follows the same standards for Oteria.